127 related articles for article (PubMed ID: 2815695)
1. [The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Shtofmakher IA
Vopr Onkol; 1989; 35(9):1063-7. PubMed ID: 2815695
[TBL] [Abstract][Full Text] [Related]
2. Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.
Vishnevsky AS; Shtofmakher JA; Bokhman JV; Tsyrlina EV; Bobrov JF; Chepick OF; Sofroniy DF
Clin Exp Obstet Gynecol; 1990; 17(3-4):159-62. PubMed ID: 2127240
[TBL] [Abstract][Full Text] [Related]
3. [Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body].
Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Shtofmakher IA
Akush Ginekol (Mosk); 1988 Nov; (11):33-6. PubMed ID: 3239679
[No Abstract] [Full Text] [Related]
4. [Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri].
Tsyrlina EV; Sofroniĭ DF; Dil'man VM; Bokhman IaV; Vishnevskiĭ AS
Vopr Onkol; 1989; 35(6):675-80. PubMed ID: 2750079
[TBL] [Abstract][Full Text] [Related]
5. [Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Fel'dkoren BI
Vopr Onkol; 1989; 35(5):594-8. PubMed ID: 2545046
[TBL] [Abstract][Full Text] [Related]
6. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
Shenderëva TS; Shvedova LA
Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal therapy of cancer of the corpus uteri].
Nigaĭ SV; Smakhtina OL; Kozbagarova RG; Nigmatullina AA
Vopr Onkol; 1983; 29(3):22-6. PubMed ID: 6836982
[TBL] [Abstract][Full Text] [Related]
8. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS
Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
[No Abstract] [Full Text] [Related]
9. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Carlson JA; Allegra JC; Day TG; Wittliff JL
Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
[No Abstract] [Full Text] [Related]
11. Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.
Vishnevsky AS; Bokhman YaV ; Loutfi G
Eur J Gynaecol Oncol; 1993; 14(2):150-3. PubMed ID: 8500499
[TBL] [Abstract][Full Text] [Related]
12. [The role of hormone therapy in the treatment of cancer of the endometrium].
Vekhova LI; Shuvaeva NI; Malysheva SF; Lebedeva AV
Vopr Onkol; 1983; 29(3):26-30. PubMed ID: 6836983
[TBL] [Abstract][Full Text] [Related]
13. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy and endocrine therapy of endometrial carcinoma].
Kanuma T; Matsuzawa M
Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
[TBL] [Abstract][Full Text] [Related]
15. [Hormonal therapy in endometrial cancer].
Piura B
Harefuah; 1985 Jul; 109(1-2):11-3. PubMed ID: 4076887
[No Abstract] [Full Text] [Related]
16. [Hormones in gynecologic oncology].
Maass H
Arch Gynecol Obstet; 1989; 245(1-4):466-73. PubMed ID: 2802734
[No Abstract] [Full Text] [Related]
17. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
Onsrud M
Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
[No Abstract] [Full Text] [Related]
18. [Cytoplasmic steroid hormone receptors in the tumors of endometrial cancer patients].
Kuz'mina ZV; Bassalyk LS; Murav'eva NI; Peskova VI; Ermilova VD
Akush Ginekol (Mosk); 1984 Apr; (4):29-32. PubMed ID: 6742345
[No Abstract] [Full Text] [Related]
19. Hormonal receptors in endometrial neoplasias.
Contreras Ortiz O; Sananes CE
Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
[TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
